Synthetic Biologics Inc. [SYN] gain 82.77% so far this year. What now?

Must read

Synthetic Biologics Inc. [AMEX: SYN] plunged by -$0.07 during the normal trading session on Tuesday and reaching a high of $0.77 during the day while it closed the day at $0.70. The company report on March 5, 2021 that Synthetic Biologics Reports 2020 Year End Operational Highlights and Financial Results.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

— Announced Washington University Has Begun Screening Patients for Enrollment in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients –.

— Reports $72.6M of Cash on Hand to Fund Clinical Programs and Extend Operations into 2023 –.

Synthetic Biologics Inc. stock has also loss -13.10% of its value over the past 7 days. However, SYN stock has inclined by 118.75% in the 3 months of the year. Over the past six months meanwhile, it has gained 41.19% and gained 82.77% year-on date.

The market cap for SYN stock reached $90.76 million, with 129.66 million shares outstanding and 127.36 million shares in the current float. Compared to the average trading volume of 23.77M shares, SYN reached a trading volume of 8767654 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Synthetic Biologics Inc. [SYN]:

FBR & Co. have made an estimate for Synthetic Biologics Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on January 06, 2017. While these analysts kept the previous recommendation, FBR Capital raised their target price from $10 to $9. The new note on the price target was released on May 06, 2016, representing the official price target for Synthetic Biologics Inc. stock. Previously, the target price had yet another raise to $10, while FBR Capital analysts kept a Outperform rating on SYN stock.

The Average True Range (ATR) for Synthetic Biologics Inc. is set at 0.10

SYN stock trade performance evaluation

Synthetic Biologics Inc. [SYN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.10. With this latest performance, SYN shares dropped by -15.92% in over the last four-week period, additionally plugging by 41.19% over the last 6 months – not to mention a rise of 122.93% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SYN stock in for the last two-week period is set at 45.22, with the RSI for the last a single of trading hit 42.30, and the three-weeks RSI is set at 47.20 for Synthetic Biologics Inc. [SYN]. The present Moving Average for the last 50 days of trading for this stock 0.8116, while it was recorded at 0.7769 for the last single week of trading, and 0.5449 for the last 200 days.

Synthetic Biologics Inc. [SYN]: An insightful look at the core fundamentals

Return on Total Capital for SYN is now -81.02, given the latest momentum, and Return on Invested Capital for the company is -69.24. Return on Equity for this stock declined to -69.99, with Return on Assets sitting at -64.60. When it comes to the capital structure of this company, Synthetic Biologics Inc. [SYN] has a Total Debt to Total Equity ratio set at 5.03. Additionally, SYN Total Debt to Total Capital is recorded at 4.79, with Total Debt to Total Assets ending up at 4.19.

Reflecting on the efficiency of the workforce at the company, Synthetic Biologics Inc. [SYN] managed to generate an average of -$1,391,182 per employee.Synthetic Biologics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.70 and a Current Ratio set at 2.70.

Earnings per share (EPS) analysis for Synthetic Biologics Inc. [SYN] stock

With the latest financial reports released by the company, Synthetic Biologics Inc. posted -0.2/share EPS, while the average EPS was predicted by analysts to be reported at -0.27/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 25.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SYN.

Synthetic Biologics Inc. [SYN]: Insider Ownership positions

There are presently around $1 million, or 1.50% of SYN stock, in the hands of institutional investors. The top three institutional holders of SYN stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 1,237,733, which is approximately 43.967% of the company’s market cap and around 0.37% of the total institutional ownership; FISHER ASSET MANAGEMENT, LLC, holding 125,698 shares of the stock with an approximate value of $88000.0 in SYN stocks shares; and BRIDGEWAY CAPITAL MANAGEMENT, LLC, currently with $77000.0 in SYN stock with ownership of nearly 0% of the company’s market capitalization.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Positions in Synthetic Biologics Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 7 institutional holders increased their position in Synthetic Biologics Inc. [AMEX:SYN] by around 579,838 shares. Additionally, 7 investors decreased positions by around 102,208 shares, while 11 investors held positions by with 1,163,652 shares. The mentioned changes placed institutional holdings at 1,845,698 shares, according to the latest SEC report filing. SYN stock had 2 new institutional investments in for a total of 120,090 shares, while 4 institutional investors sold positions of 204 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam